Scientific Program - Friday 12 April

Print
Please see below the CODHy Scientific Program.
Please click on the appropriate day to view the relevant program.
 
Friday 12 April, 2019   Saturday 13 April, 2019
 
Friday 12 April, 2019
 
HALL A
09:15-10:00
Plenary 1 | Key Note Lecture
Chairs:
Stefano Del Prato, Italy and Itamar Raz, Israel
09:15-09:45
Diabetes prevention and early treatment: Stefano Del Prato, Italy
09:45-10:00
Discussion
 
HALL A
10:00-11:30
Session 2 | Diabetes
Chairs:
Daniel Abouganem, Panama and Antonio Ceriello, Italy
 
Should HbA1c still be the main target for diabetes treatment?
10:00-10:10
Yes: Baruch Itzhak, Israel
10:10-10:20
No: Antonio Ceriello, Italy
10:20-10:25
Q&A
10:25-10:27
Debate summary: Antonio Ceriello, Italy
10:27-10:30
Vote - Yes/No
 
Should we change the A1C target in newly diagnosed patients?
10:30-10:40
Yes: Ofri Mosenzon, Israel
10:40-10:50
No: Eberhard Standl, Germany
10:50-10:55
Q&A
10:55-10:57
Debate summary: Ofri Mosenzon, Israel
10:57-11:00
Vote - Yes/No
 
SGLT2 –Safe Drug?
11:00-11:10
Yes: Francesco Giorgino, Italy
11:10-11:20
No: Gian Paulo Fadini, Italy
11:20-11:25
Q&A
11:25-11:27
Debate summary: Daniel Abouganem, Panama
11:27-11:30
Vote - Yes/No
11:30-12:00
VISIT EXHIBITS & COFFEE BREAK
 
HALL B
10:00-11:30
Session 3 | Devices and Digital Therapy in T2D - Pumps
Chairs:
Katharine Barnard, UK and Eytan Roitman, Israel
 
Should insulin pump treatment be a part of diabetes guidelines as an option?
10:00-10:15
Yes: Katharine Barnard, UK
10:15-10:30
No: Geremia Bolli, Italy
10:30-10:35
Q&A
10:35-10:40
Debate summary: Katharine Barnard, UK
10:40-10:45
Vote - Yes/No
 
Connected devices
10:45-11:00
The next step: Paolo Pozzilli, Italy
11:00-11:15
Too much information: Eytan Roitman, Israel
11:15-11:20
Q&A
11:20-11:25
Debate summary: Eytan Roitman, Israel
11:25-11:30
Vote - Yes/No
 
HALL A
12:00-13:30
Session 4 | Diabetes
Chairs:
Guang Ning, China and Luc Van Gaal, Belgium  
 
Should we reduce weight in elderly T2D patients?
12:00-12:10
Yes: Weiqing Wang, China
12:10-12:20
No: Luc Van Gaal, Belgium
12:20-12:25
Q&A
12:25-12:27
Debate summary: Luc Van Gaal, Belgium
12:27-12:30
Vote Yes/No
 
Should we treat T2D with testosterone?
12:30-12:40
Yes: Farid Saad, Germany
12:40-12:50
No: Roy Eldor, Israel
12:50-12:55
Q&A
12:55-12:57
Debate summary: Farid Saad, Germany
12:57-13:00
Vote Yes/No
 
Is LDL still the best lipid predictor for cardiovascular events?
13:00-13:10
Yes: Shlomo Vinker, Israel
13:10-13:20
No: Luc Van Gaal, Belgium
13:20-13:25
Q&A
13:25-13:27
Debate summary: Shlomo Vinker, Israel
13:27-13:30
Vote Yes/No
 
HALL B
12:00-13:30
Session 5 | Devices and Digital Therapy in T2D - CGM
Chairs:
Francesco Giorgino, Italy and Eytan Roitman, Israel
 
Do we need BGM in the era of CGM/FGM?
12:00-12:15
Yes: Paolo Di Bartolo, Italy
12:15-12:30
No: Eytan Roitman, Israel
12:30-12:35
Q&A
12:35-12:40
Debate summary: Paolo Di Bartolo, Italy
12:40-12:45
Vote Yes/No
 
Should T2D use CGM regularly?
12:45-13:00
Yes: Philip Home, UK
13:00-13:15
No: Francesco Giorgino, Italy
13:15-13:20
Q&A
13:20-13:25
Debate summary: Philip Home, UK
13:25-13:30
Vote Yes/No
13:30-14:00
VISIT EXHIBITS & LUNCH
 
HALL A
14:00-15:00
Session 6 | Break through in the prevention and treatment in HF
Chairs:
Itamar Raz, Israel and Giuseppe M.C. RosanoUK
14:00-14:20
HF in diabetes can we close the gap: Giuseppe M.C. Rosano, UK
14:20-14:40
DECLARE – Break through in the prevention and treatment of cardio renal outcome in T2D: Itamar Raz, Israel
14:40-15:00
Discussion


15:00-15:30
VISIT EXHIBITS & DESSERT BREAK - Poster Round with Faculty Members
 
HALL A
15:30-17:00
Session 7 | Diabetes
Chairs:
Philip Home, UK and Paolo Pozzilli, Italy
 
Is insulin still the best injectable therapy?
15:30-15:40
Yes: Geremia Bolli, Italy
15:40-15:50
No: Eberhard Standl, Germany
15:50-15:55
Q&A
15:55-15:57
Debate summary: Geremia Bolli, Italy
15:57-16:00
Vote Yes/No
 
Is prandial Insulin Dead in T2D?
16:00-16:10
Yes: Philip Home, UK
16:10-16:20
No: Geremia Bolli, Italy
16:20-16:25
Q&A
16:25-16:27
Debate summary: Paolo Pozzilli, Italy
16:27-16:30
Vote Yes/No
16:30-16:50
Is preservation of C-peptide secretion a target of T2D therapy? Paolo Pozzilli, Italy
16:50-16:57
Discussion
16:57-17:00
Vote Yes/No
 
HALL B
15:30-17:00
Session 8 | Hypertension and Diabetes
Chairs:
Ehud Grossman, Israel and Anna Solini, Italy
 
Prevention of cardiac and renal events in primary prevention: Should we prefer SGLT2 over GLP1 and other ADD?
15:30-15:40
Yes: Anna Solini, Italy
15:40-15:50
No: Ofri Mosenzon, Israel
15:50-15:55
Q&A
15:55-15:57
Debate summary: Ehud Grossman, Israel
15:57-16:00
Vote Yes/No
16:00-16:20
Definition and diagnosis of hypertension in diabetic patients: Ehud Grossman, Israel
16:20-16:27
Discussion
16:27-16:30
Vote Yes/No
16:30-16:50
Is sodium restriction effective for lowering blood pressure? Graham MacGregor, UK
16:50-16:57
Discussion
16:57-17:00
Vote Yes/No
END OF DAY 1